Two Sigma Securities, LLC Nova Bay Pharmaceuticals, Inc. Transaction History

Two Sigma Securities, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.11 - $147.37 $2,271 - $3.04 Million	-20,648 Reduced 58.37%	14,725 $2,000
Q2 2022 Aug 15, 2022	BUY	$0.18 - $0.31 $6,367 - $10,965	35,373 New	35,373 $9,000
Q3 2020 Nov 16, 2020	SELL	$0.72 - $1.61 $8,550 - $19,120	-11,876 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$0.71 - $1.29 $8,431 - $15,320	11,876 New	11,876 $14,000
Q3 2019 Nov 14, 2019	SELL	$0.45 - $1.73 $9,169 - $35,250	-20,376 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$0.28 - $3.1 $5,705 - $63,165	20,376 New	20,376 $34,000

2.94K

Ticker NBY
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,988,400
Market Cap $46.8M
Description
NovaBay Pharmaceuticals, Inc., a pharmaceutical company, develops and sells eyecare and skincare products in the United States and internationally. It offers Avenova, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products under the NeutroPhase and Phase...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.